2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow IgA Vasculitis: new trials by email Literature Review of IgA Vasculitis trials Research Report on IgA Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases Sparsentan - Focal Segmental Glomerulosclerosis, Minimal Change Disease | Phase 2 | Recruiting | Travere Therapeutics, Inc. | 67 | 2021-08-12 | 2026-05-12 |
| A Randomized Multicenter Study for Isolated Skin Vasculitis Colchicine, Dapsone, Azathioprine - Primary Cutaneous Vasculitis, Cutaneous Polyarteritis Nodosa | Phase 2 | Recruiting | University of Pennsylvania | 90 | 2017-01-01 | 2026-08-20 |
Glomerulonephritis, IGA (1) · Glomerulosclerosis, Focal Segmental (1) · Macular dystrophy, corneal type 1 (1) · Nephritis, Hereditary (1) · Nephrosis, Lipoid (1)
Blood Coagulation Disorders (2) · Cardiovascular Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhage (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Hypersensitivity (2) · Immune Complex Diseases (2) · Immune System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Purpura (2) · Signs and Symptoms (2) · Skin Diseases (2)
Azathioprine (1) · Colchicine (1) · Dapsone (1) · sparsentan (1)
Travere Therapeutics, Inc. (1) · University of Pennsylvania (1)
United States (2) · Canada (1) · Germany (1) · Italy (1) · Japan (1) · Netherlands (1) · Poland (1) · Spain (1) · Sweden (1) · United Kingdom (1)
Christian Pagnoux, MD, MPH, MSc (1) · Radko Komers, MD, PhD (1) · Robert Micheletti, MD (1)
PMID 32345372, PMID 36853224, PMID 38724717, PMID 40938675, PMID 42384439
U54AR057319 (1)